These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 19219856

  • 1. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).
    Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P.
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec 05; 150B(8):1050-62. PubMed ID: 19219856
    [Abstract] [Full Text] [Related]

  • 2. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM, Fawzy N, Fawzi MM, Karam RA.
    J Psychiatr Res; 2012 Jun 05; 46(6):762-6. PubMed ID: 22521161
    [Abstract] [Full Text] [Related]

  • 3. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
    Wang Y, Zhang H, Li Y, Wang Z, Fan Q, Yu S, Lin Z, Xiao Z.
    J Affect Disord; 2015 Nov 01; 186():7-12. PubMed ID: 26209750
    [Abstract] [Full Text] [Related]

  • 4. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).
    Hemmings SM, Kinnear CJ, Van der Merwe L, Lochner C, Corfield VA, Moolman-Smook JC, Stein DJ.
    World J Biol Psychiatry; 2008 Nov 01; 9(2):126-34. PubMed ID: 17853300
    [Abstract] [Full Text] [Related]

  • 5. Is Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Associated with Obsessive-Compulsive Disorder? A Meta-Analysis.
    Wang S, Xu X, Yan P, Song M, Li J, Wang S.
    Psychiatr Danub; 2019 Jun 01; 31(2):141-147. PubMed ID: 31291217
    [Abstract] [Full Text] [Related]

  • 6. Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder.
    Fullana MA, Alonso P, Gratacòs M, Jaurrieta N, Jiménez-Murcia S, Segalàs C, Real E, Estivill X, Menchón JM.
    Eur Psychiatry; 2012 Jul 01; 27(5):386-90. PubMed ID: 22153732
    [Abstract] [Full Text] [Related]

  • 7. BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response.
    Taj M J RJ, Ganesh S, Shukla T, Deolankar S, Nadella RK, Sen S, Purushottam M, Reddy YCJ, Jain S, Viswanath B.
    Asian J Psychiatr; 2018 Dec 01; 38():65-69. PubMed ID: 29079096
    [Abstract] [Full Text] [Related]

  • 8. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R, Gürvit H, Ozata B, Oztürk N, Ertekin BA, Ertekin E, Baran B, Kalem SA, Büyükgök D, Direskeneli GS.
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct 01; 159B(7):850-8. PubMed ID: 22911909
    [Abstract] [Full Text] [Related]

  • 9. Exploring yale-brown obsessive-compulsive scale symptom structure in Iranian OCD patients using item-based factor analysis.
    Asadi S, Daraeian A, Rahmani B, Kargari A, Ahmadiani A, Shams J.
    Psychiatry Res; 2016 Nov 30; 245():416-422. PubMed ID: 27620324
    [Abstract] [Full Text] [Related]

  • 10. Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive-compulsive disorder.
    Harika-Germaneau G, Langbour N, Patri S, Solinas M, Chatard A, Millet B, Hashemian F, Pérault-Pochat MC, Jaafari N, Lafay-Chebassier C.
    CNS Spectr; 2022 Oct 30; 27(5):645-651. PubMed ID: 34313207
    [Abstract] [Full Text] [Related]

  • 11. Factor analysis of Y-BOCS checklist and severity scale among patients with schizophrenia.
    Grover S, Dua D, Chakrabarti S, Avasthi A.
    Asian J Psychiatr; 2017 Apr 30; 26():141-145. PubMed ID: 28483079
    [Abstract] [Full Text] [Related]

  • 12. Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder.
    Márquez L, Camarena B, Hernández S, Lóyzaga C, Vargas L, Nicolini H.
    Eur Neuropsychopharmacol; 2013 Nov 30; 23(11):1600-5. PubMed ID: 23999029
    [Abstract] [Full Text] [Related]

  • 13. The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.
    Tükel R, Ozata B, Oztürk N, Ertekin BA, Ertekin E, Direskeneli GS.
    J Clin Neurosci; 2014 May 30; 21(5):790-3. PubMed ID: 24291483
    [Abstract] [Full Text] [Related]

  • 14. Do obsessive-compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population.
    Liu S, Cui J, Niu Z, Yi M, Zhang X, Che F, Ma X.
    World J Biol Psychiatry; 2015 May 30; 16(8):602-9. PubMed ID: 25771937
    [Abstract] [Full Text] [Related]

  • 15. BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder.
    Hemmings SM, Lochner C, van der Merwe L, Cath DC, Seedat S, Stein DJ.
    J Psychiatr Res; 2013 Dec 30; 47(12):1857-63. PubMed ID: 24050777
    [Abstract] [Full Text] [Related]

  • 16. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity.
    Hasler G, LaSalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D, Greenberg BD, Murphy DL.
    Psychiatry Res; 2005 Jun 15; 135(2):121-32. PubMed ID: 15893825
    [Abstract] [Full Text] [Related]

  • 17. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism.
    Hasler G, Kazuba D, Murphy DL.
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun 05; 141B(4):403-8. PubMed ID: 16583440
    [Abstract] [Full Text] [Related]

  • 18. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study.
    Hasler G, Pinto A, Greenberg BD, Samuels J, Fyer AJ, Pauls D, Knowles JA, McCracken JT, Piacentini J, Riddle MA, Rauch SL, Rasmussen SA, Willour VL, Grados MA, Cullen B, Bienvenu OJ, Shugart YY, Liang KY, Hoehn-Saric R, Wang Y, Ronquillo J, Nestadt G, Murphy DL, OCD Collaborative Genetics Study.
    Biol Psychiatry; 2007 Mar 01; 61(5):617-25. PubMed ID: 17027929
    [Abstract] [Full Text] [Related]

  • 19. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
    Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X.
    Biol Psychiatry; 2008 Mar 15; 63(6):619-28. PubMed ID: 17884018
    [Abstract] [Full Text] [Related]

  • 20. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder.
    Katerberg H, Cath DC, Denys DA, Heutink P, Polman A, van Nieuwerburgh FC, Deforce DL, Bochdanovits Z, van Balkom AJ, den Boer JA.
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan 05; 153B(1):167-76. PubMed ID: 19521967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.